USD 1.06
(-4.5%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2023 | -26.37 Million USD | 1.17% |
2022 | -26.68 Million USD | -68.24% |
2021 | -15.86 Million USD | -370.97% |
2020 | -3.36 Million USD | -112.27% |
2019 | -1.58 Million USD | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 Q2 | -12.27 Million USD | -201.92% |
2024 Q1 | -4.06 Million USD | -4.21% |
2023 Q3 | -7.02 Million USD | 3.33% |
2023 FY | -26.37 Million USD | 1.17% |
2023 Q2 | -7.27 Million USD | 14.69% |
2023 Q1 | -8.52 Million USD | 1.66% |
2023 Q4 | -3.9 Million USD | 44.5% |
2022 Q4 | -8.66 Million USD | -49.06% |
2022 Q3 | -5.81 Million USD | 11.94% |
2022 Q2 | -6.6 Million USD | -19.22% |
2022 Q1 | -5.53 Million USD | 3.66% |
2022 FY | -26.68 Million USD | -68.24% |
2021 Q3 | -4.73 Million USD | -19.26% |
2021 FY | -15.86 Million USD | -370.97% |
2021 Q4 | -5.74 Million USD | -21.39% |
2021 Q2 | -3.97 Million USD | -182.61% |
2021 Q1 | -1.4 Million USD | -91.64% |
2020 Q3 | -791.82 Thousand USD | 10.9% |
2020 Q2 | -888.67 Thousand USD | 6.85% |
2020 Q4 | -733.19 Thousand USD | 7.4% |
2020 Q1 | -954.03 Thousand USD | -33.71% |
2020 FY | -3.36 Million USD | -112.27% |
2019 Q4 | -713.53 Thousand USD | 0.0% |
2019 FY | -1.58 Million USD | 0.0% |
Name | Operating Income | Operating Income Difference |
---|---|---|
Alignment Healthcare, Inc. | -127.81 Million USD | 79.367% |
Clover Health Investments, Corp. | -208.54 Million USD | 87.354% |
NewGenIvf Group Limited | 42.24 Thousand USD | 62532.929% |